The first in human study is intended to evaluate the safety and tolerability of single ascending doses of RVP-001 in healthy adult volunteers, and to determine the pharmacokinetics and elimination of RVP-001 in healthy adult volunteers.
The objectives of this trial are:~To evaluate the safety and tolerability of single ascending doses of RVP-001 in healthy adult volunteers~To determine the pharmacokinetics and elimination of RVP-001 in healthy adult volunteers.